Kelly L Harms, MD, PhD

Kelly L. Harms, MD, PhD is the Lewis and Lillian Becker Professor of Dermatology and Clinical Professor in the Department of Dermatology at Michigan Medicine. Board-certified in dermatology and Mohs micrographic surgery, she specializes in the comprehensive management of rare and high-risk skin cancers, including basal cell and squamous cell carcinoma, melanoma, Merkel cell carcinoma, and other complex cutaneous malignancies.

As Division Chief of Cutaneous Surgery and Oncology and Director of the Multidisciplinary Cutaneous Oncology Program, Dr. Harms leads advanced clinical care at the Rogel Cancer Center. Her clinical practice focuses on Mohs micrographic surgery and associated reconstruction, as well as the complex multidisciplinary management of care for patients with advanced skin cancer. She is a nationally recognized expert who actively contributes to the National Comprehensive Cancer Network clinical care guidelines for Merkel cell carcinoma.

Dr. Harms' research portfolio encompasses skin cancer biology, epidemiology, and therapeutic interventions, with a primary goal of advancing diagnostic and treatment strategies for rare and high-risk skin cancers. Her peer-reviewed scholarship has provided crucial disease insights and clinical guidance for physicians, patients, and healthcare teams.

She completed her medical education through the Medical Scientist Training Program at the University of Alabama, earning both her MD and PhD. Her dermatology residency and Mohs micrographic surgery fellowship were completed at Michigan Medicine, where she now leads innovative clinical and research programs in dermatologic surgery and oncology.